首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1776821

迷走神經刺激市場：全球產業分析、規模、佔有率、成長、趨勢與預測，2025-2032

Vagus Nerve Stimulation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日期: 2025年07月23日 | 出版商:

Persistence Market Research | 英文 200 Pages | 商品交期: 2-5個工作天內

價格

簡介目錄

Persistence Market Research 最近發布了一份關於全球迷走神經刺激（VNS）市場的全面分析報告。本報告對重要市場動態進行了全面評估，包括市場促進因素、趨勢、機會和挑戰，並對市場結構提供了詳細的洞察。

關鍵見解

迷走神經刺激市場規模（2025年）：5.423億美元
市場規模預測（以金額為準，2032年）：10.134億美元
全球市場成長率（2025-2032年年複合成長率）：9.3%

迷走神經刺激市場-分析範圍

迷走神經刺激是一種神經調節技術，用於治療多種神經和精神疾病，包括癲癇、抗治療性憂鬱症、偏頭痛，以及近期出現的發炎和自體免疫疾病。迷走神經刺激（VNS）市場為醫院、神經科診所、門診手術中心和居家醫療機構提供植入式和非侵入式迷走神經刺激（VNS）設備。神經系統疾病盛行率的上升、人們對生物電子醫學的興趣日益濃厚，以及支持迷走神經刺激新型治療應用的臨床研究的不斷擴展，推動了迷走神經刺激市場的成長。

市場成長動力：

全球迷走神經刺激市場的發展受到神經和精神疾病替代療法日益成長的需求的推動。癲癇和抗治療性憂鬱症的發生率不斷上升，尤其是在高齡化社會中，這促使人們將迷走神經刺激（VNS）作為一種安全有效的干涉措施。越來越多的美國食品藥物管理局（FDA）核准，以及越來越多的臨床試驗探索VNS在偏頭痛、纖維肌痛甚至發炎性腸道疾病腸道疾病等疾病中的應用，擴大這種治療方法的範圍。微型植入式系統、體外刺激器和人工智慧VNS設備等技術進步，透過提高治療精準度和患者便利性，進一步刺激了市場擴張。

市場限制：

儘管迷走神經刺激（VNS）臨床前景廣闊，但由於設備成本高且償付範圍有限，市場面臨許多阻礙，尤其是在新興經濟體。手術植入迷走神經刺激系統（VNS）有手術風險和術後併發症，這給患者和醫護人員帶來了不確定性。監管挑戰以及對迷走神經刺激（VNS）新用途進行廣泛臨床檢驗的需求，可能會延遲其市場准入並增加研發支出。此外，患者和全科醫生對迷走神經刺激（VNS）作為治療方法的認知度較低，限制了其廣泛應用。

市場機會：

迷走神經刺激（VNS）市場擁有良好的成長潛力，這得益於非侵入式迷走神經刺激（VNS）設備的開發，這些設備可以消除手術風險並降低治療成本。其在精神病學和免疫學領域的應用擴展，例如創傷後壓力症候群（PTSD）、焦慮類風濕性關節炎和克隆氏症，將帶來重要的新收益來源。與數位健康平台（例如行動控制的迷走神經刺激設備和遠端監控系統）的整合，可以提高患者的參與度和治療效果。醫療技術公司與學術研究機構之間的策略夥伴關係預計將加速生物電子醫療領域的創新和商業化。

本報告回答的關鍵問題

影響迷走神經刺激市場全球成長的關鍵促進因素有哪些？
哪些設備類型和治療應用塑造 VNS 未來應用？
神經調節和穿戴式裝置的創新如何改變 VNS 市場格局？
迷走神經刺激市場的主要企業有哪些？他們採取哪些策略舉措？
全球 VNS 生態系中存在哪些新興趨勢和尚未開發的機會？

主要亮點
- 市場規模預測（以數量為基礎）
- 市場規模及年成長率（以金額為準）
- 絕對的商機
市場規模分析與預測（以金額為準）
- 歷史市場規模分析（以金額為準，2019-2024）
- 市場規模分析與預測（以金額為準，2025-2032）
全球迷走神經刺激市場展望：依產品
- 引言/主要發現
- 歷史市場規模分析：依產品（價值和數量，2019-2024）
- 市場規模分析和預測：依產品（價值和數量基礎，2025-2032年）
  - 植入式神經刺激裝置
  - 外接式、非侵入性迷走神經刺激裝置
- 市場吸引力分析：依產品
全球迷走神經刺激市場前景：依應用
- 引言/主要發現
- 歷史市場規模分析：依應用（以金額為準，2019-2024）
- 市場規模分析和預測：依應用（以金額為準，2025-2032）
  - 癲癇
  - 憂鬱症
  - 偏頭痛
  - 其他
- 市場吸引力分析：依應用
全球迷走神經刺激市場前景：依最終用戶
- 引言/主要發現
- 歷史市場規模分析：依最終用戶（以金額為準，2019-2024年）
- 市場規模分析與預測：依最終用戶（以金額為準，2025-2032）
  - 醫院
  - 專科診所
  - 門診手術中心
  - 學術研究機構
  - 其他
- 市場吸引力分析：依最終用戶

第6章全球迷走神經刺激市場展望：依地區

主要亮點
歷史市場規模分析：依地區（以金額為準，2019-2024年）
市場規模分析及預測：依地區（以金額為準，2025-2032）
- 北美洲
- 歐洲
- 東亞
- 南亞和大洋洲
- 拉丁美洲
- 中東和非洲
市場吸引力分析：依地區

第7章北美迷走神經刺激市場展望

第8章歐洲迷走神經刺激市場展望

第9章東亞迷走神經刺激市場展望

第10章南亞與大洋洲迷走神經刺激市場展望

第11章拉丁美洲迷走神經刺激市場展望

第12章中東與非洲迷走神經刺激市場展望

第13章競爭格局

市場佔有率分析（2024年）
市場結構
- 競爭強度圖：依市場
- 競爭儀表板
公司簡介（詳情：概述、財務狀況、策略、最新發展）
- Soterix Medical Inc.
- LivaNova PLC
- SetPoint Medical
- Vagutism
- tVNS Technologies GmbH
- electroCore, Inc.
- Adriakaim, Inc.
- MicroTransponder Inc.
- Parasym, Ltd.
- Pulsetto
- Teliatry, Inc.
- biolitec（R）Holding GmbH &Co KG
- AURIMOD GMBH
- Evren Technologies, Inc.
- NeurGear
- Hoolest
- Neuvana
- BioSelf Technology Ltd.

第14章附錄

分析方法
分析假設
首字母縮寫和簡稱

簡介目錄

Product Code: PMRREP34750

Persistence Market Research has recently released a comprehensive report on the worldwide market for vagus nerve stimulation (VNS). The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

Vagus Nerve Stimulation Market Size (2025E): USD 542.3 Mn
Projected Market Value (2032F): USD 1,013.4 Mn
Global Market Growth Rate (CAGR 2025 to 2032): 9.3%

Vagus Nerve Stimulation Market - Report Scope:

Vagus nerve stimulation is a neuromodulation technique used to treat various neurological and psychiatric disorders, including epilepsy, treatment-resistant depression, migraine, and more recently, inflammatory and autoimmune conditions. The VNS market serves hospitals, neurological clinics, ambulatory surgical centers, and homecare settings, offering both implantable and non-invasive VNS devices. Growth is driven by the rising prevalence of neurological conditions, growing interest in bioelectronic medicine, and expanding clinical research supporting new therapeutic applications of vagus nerve stimulation.

Market Growth Drivers:

The global vagus nerve stimulation market is driven by a growing demand for alternative therapies for neurological and psychiatric disorders. Rising rates of epilepsy and treatment-resistant depression-particularly in aging populations-are fueling adoption of VNS as a safe and effective intervention. Increasing FDA approvals and clinical trials exploring VNS applications in conditions like migraine, fibromyalgia, and even inflammatory bowel disease are expanding the therapy's reach. Technological advances such as miniaturized implantable systems, external wearable stimulators, and AI-enabled VNS devices further stimulate market expansion by enhancing treatment precision and patient convenience.

Market Restraints:

Despite its clinical promise, the VNS market faces limitations due to high device costs and limited reimbursement coverage, especially in developing economies. Surgical implantation of VNS systems involves procedural risks and postoperative complications, creating apprehension among patients and healthcare providers. Regulatory challenges and the need for extensive clinical validation for emerging applications of VNS can slow market entry and increase R\&D expenditures. In addition, low awareness among patients and general practitioners about VNS as a treatment modality limits its widespread adoption.

Market Opportunities:

The VNS market holds promising growth potential through the development of non-invasive VNS devices, which eliminate surgical risks and lower treatment costs. Expansion into psychiatric and immunological applications, such as PTSD, anxiety disorders, rheumatoid arthritis, and Crohn's disease, presents significant new revenue streams. Integration with digital health platforms, such as mobile-controlled VNS devices and remote monitoring systems, improves patient engagement and outcomes. Strategic partnerships between medtech firms and academic research institutions are expected to accelerate innovation and commercialization in the bioelectronic medicine space.

Key Questions Answered in the Report:

What are the primary drivers influencing the global growth of the vagus nerve stimulation market?
Which device types and therapeutic applications are shaping the future of VNS adoption?
How are innovations in neuromodulation and wearable devices transforming the VNS market landscape?
Who are the leading players in the vagus nerve stimulation market and what strategic initiatives are they pursuing?
What emerging trends and untapped opportunities exist in the global VNS ecosystem?

Competitive Intelligence and Business Strategy:

These firms are investing in next-generation non-invasive VNS systems and exploring applications in mental health and autoimmune diseases. Collaborations with neurology departments, regulatory bodies, and digital health startups are enhancing their market positioning. Additionally, efforts to improve device affordability and expand insurance coverage are helping these players reach underserved markets.

Key Companies Profiled:

Soterix Medical Inc.
LivaNova PLC
SetPoint Medical
Vagutism
tVNS Technologies GmbH
electroCore, Inc.
Adriakaim, Inc.
MicroTransponder Inc.
Parasym, Ltd.
Pulsetto
Teliatry, Inc.
biolitec(R) Holding GmbH & Co KG
AURIMOD GMBH
Evren Technologies, Inc.
NeurGear
Hoolest
Neuvana
BioSelf Technology Ltd.

Vagus Nerve Stimulation Market Research Segmentation:

By Product:

Implantable VNS Device
External Non-invasive VNS Device

By Application:

Epilepsy
Depression
Migraine
Others

By End-user:

Hospitals
Specialty Clinics
Ambulatory Surgical Centres
Academic & Research Institutes
Others

By Region:

North America
Europe
East Asia
South Asia and Oceania
Latin America
Middle East and Africa

1. Executive Summary

1.1. Global Vagus Nerve Stimulation Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Key Trends
2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Product Adoption Analysis
3.2. Regulatory Landscape
3.3. Value Chain Analysis
3.4. Key Deals and Mergers
3.5. PESTLE Analysis
3.6. Porter's Five Force Analysis

4. Price Analysis, 2024A

4.1. Key Highlights
4.2. Key Factors Impacting Product Prices
4.3. Pricing Analysis, By Product
4.4. Regional Prices and Product Preferences

5. Global Vagus Nerve Stimulation Market Outlook

5.1. Key Highlights
- 5.1.1. Market Volume (Units) Projections
- 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
- 5.1.3. Absolute $ Opportunity
5.2. Market Size (US$ Mn) Analysis and Forecast
- 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
- 5.2.2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
5.3. Global Vagus Nerve Stimulation Market Outlook: Product
- 5.3.1. Introduction / Key Findings
- 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2024
- 5.3.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  - 5.3.3.1. Implantable VNS Device
  - 5.3.3.2. External Non-invasive VNS Device
- 5.3.4. Market Attractiveness Analysis: Product
5.4. Global Vagus Nerve Stimulation Market Outlook: Application
- 5.4.1. Introduction / Key Findings
- 5.4.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
- 5.4.3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  - 5.4.3.1. Epilepsy
  - 5.4.3.2. Depression
  - 5.4.3.3. Migraine
  - 5.4.3.4. Others
- 5.4.4. Market Attractiveness Analysis: Application
5.5. Global Vagus Nerve Stimulation Market Outlook: End User
- 5.5.1. Introduction / Key Findings
- 5.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
- 5.5.3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  - 5.5.3.1. Hospitals
  - 5.5.3.2. Specialty Clinics
  - 5.5.3.3. Ambulatory Surgical Centers
  - 5.5.3.4. Academic & Research Institutes
  - 5.5.3.5. Others
- 5.5.4. Market Attractiveness Analysis: End User

6. Global Vagus Nerve Stimulation Market Outlook: Region

6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
6.3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia and Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region

7. North America Vagus Nerve Stimulation Market Outlook

7.1. Key Highlights
7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Product
- 7.2.3. By Application
- 7.2.4. By End User
7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. U.S.
- 7.3.2. Canada
7.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 7.4.1. Implantable VNS Device
- 7.4.2. External Non-invasive VNS Device
7.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 7.5.1. Epilepsy
- 7.5.2. Depression
- 7.5.3. Migraine
- 7.5.4. Others
7.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 7.6.1. Hospitals
- 7.6.2. Specialty Clinics
- 7.6.3. Ambulatory Surgical Centers
- 7.6.4. Academic & Research Institutes
- 7.6.5. Others
7.7. Market Attractiveness Analysis

8. Europe Vagus Nerve Stimulation Market Outlook

8.1. Key Highlights
8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Product
- 8.2.3. By Application
- 8.2.4. By End User
8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. Germany
- 8.3.2. France
- 8.3.3. U.K.
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Russia
- 8.3.7. Turkey
- 8.3.8. Rest of Europe
8.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 8.4.1. Implantable VNS Device
- 8.4.2. External Non-invasive VNS Device
8.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 8.5.1. Epilepsy
- 8.5.2. Depression
- 8.5.3. Migraine
- 8.5.4. Others
8.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 8.6.1. Hospitals
- 8.6.2. Specialty Clinics
- 8.6.3. Ambulatory Surgical Centers
- 8.6.4. Academic & Research Institutes
- 8.6.5. Others
8.7. Market Attractiveness Analysis

9. East Asia Vagus Nerve Stimulation Market Outlook

9.1. Key Highlights
9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Product
- 9.2.3. By Application
- 9.2.4. By End User
9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
9.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 9.4.1. Implantable VNS Device
- 9.4.2. External Non-invasive VNS Device
9.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 9.5.1. Epilepsy
- 9.5.2. Depression
- 9.5.3. Migraine
- 9.5.4. Others
9.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 9.6.1. Hospitals
- 9.6.2. Specialty Clinics
- 9.6.3. Ambulatory Surgical Centers
- 9.6.4. Academic & Research Institutes
- 9.6.5. Others
9.7. Market Attractiveness Analysis

10. South Asia & Oceania Vagus Nerve Stimulation Market Outlook

10.1. Key Highlights
10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Product
- 10.2.3. By Application
- 10.2.4. By End User
10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. India
- 10.3.2. Southeast Asia
- 10.3.3. ANZ
- 10.3.4. Rest of South Asia & Oceania
10.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 10.4.1. Implantable VNS Device
- 10.4.2. External Non-invasive VNS Device
10.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 10.5.1. Epilepsy
- 10.5.2. Depression
- 10.5.3. Migraine
- 10.5.4. Others
10.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 10.6.1. Hospitals
- 10.6.2. Specialty Clinics
- 10.6.3. Ambulatory Surgical Centers
- 10.6.4. Academic & Research Institutes
- 10.6.5. Others
10.7. Market Attractiveness Analysis

11. Latin America Vagus Nerve Stimulation Market Outlook

11.1. Key Highlights
11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Product
- 11.2.3. By Application
- 11.2.4. By End User
11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest of Latin America
11.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 11.4.1. Implantable VNS Device
- 11.4.2. External Non-invasive VNS Device
11.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 11.5.1. Epilepsy
- 11.5.2. Depression
- 11.5.3. Migraine
- 11.5.4. Others
11.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 11.6.1. Hospitals
- 11.6.2. Specialty Clinics
- 11.6.3. Ambulatory Surgical Centers
- 11.6.4. Academic & Research Institutes
- 11.6.5. Others
11.7. Market Attractiveness Analysis

12. Middle East & Africa Vagus Nerve Stimulation Market Outlook

12.1. Key Highlights
12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 12.2.1. By Country
- 12.2.2. By Product
- 12.2.3. By Application
- 12.2.4. By End User
12.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 12.3.1. GCC Countries
- 12.3.2. Egypt
- 12.3.3. South Africa
- 12.3.4. Northern Africa
- 12.3.5. Rest of Middle East & Africa
12.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 12.4.1. Implantable VNS Device
- 12.4.2. External Non-invasive VNS Device
12.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 12.5.1. Epilepsy
- 12.5.2. Depression
- 12.5.3. Migraine
- 12.5.4. Others
12.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 12.6.1. Hospitals
- 12.6.2. Specialty Clinics
- 12.6.3. Ambulatory Surgical Centers
- 12.6.4. Academic & Research Institutes
- 12.6.5. Others
12.7. Market Attractiveness Analysis

13. Competition Landscape

13.1. Market Share Analysis, 2024
13.2. Market Structure
- 13.2.1. Competition Intensity Mapping By Market
- 13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 13.3.1. Soterix Medical Inc.
  - 13.3.1.1. Overview
  - 13.3.1.2. Segments and Product
  - 13.3.1.3. Key Financials
  - 13.3.1.4. Market Developments
  - 13.3.1.5. Market Strategy
- 13.3.2. LivaNova PLC
- 13.3.3. SetPoint Medical
- 13.3.4. Vagutism
- 13.3.5. tVNS Technologies GmbH
- 13.3.6. electroCore, Inc.
- 13.3.7. Adriakaim, Inc.
- 13.3.8. MicroTransponder Inc.
- 13.3.9. Parasym, Ltd.
- 13.3.10. Pulsetto
- 13.3.11. Teliatry, Inc.
- 13.3.12. biolitec(R) Holding GmbH & Co KG
- 13.3.13. AURIMOD GMBH
- 13.3.14. Evren Technologies, Inc.
- 13.3.15. NeurGear
- 13.3.16. Hoolest
- 13.3.17. Neuvana
- 13.3.18. BioSelf Technology Ltd.